Abbott Diagnostics Medical Determine™ HIV-1/2 - HSA Registration DE0506958
Access comprehensive regulatory information for Abbott Diagnostics Medical Determine™ HIV-1/2 in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0506958 and owned by Abbott Diagnostics Medical Co., Ltd.. The device was registered on June 15, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Determine™ HIV-1/2 is an in vitro, visually read, qualitative immunoassay for the detection of antibodies to HIV-1 and HIV-2 in human serum, plasma or whole blood. The test is intended as an aid to detect antibodies to HIV-1 and HIV-2 from infected individuals. A reactive/positive HIV test result must be followed by confirmatory testing before a final diagnosis of HIV infection can be made.